<DOC>
	<DOCNO>NCT01386034</DOCNO>
	<brief_summary>The specific aim study determine whether oral citrulline administration enhance whole body protein synthesis patient intestinal failure . Protein metabolism assess use intravenous infusion stable isotope label leucine . The investigator hypothesize citrulline supplementation decrease leucine oxidation without alter proteolysis , consequently stimulate protein synthesis .</brief_summary>
	<brief_title>Effects Oral Citrulline Protein Metabolism Patients With Intestinal Failure ( Citrugrêle 2 )</brief_title>
	<detailed_description />
	<criteria>Adult 18 75 year Patient short bowel syndrome Patient incompetent small intestine intestinal resection Patient feed orally beyond 6 week surgery Absence early supplementation citrulline , glutamine , ornithine aketoglutarate , stimol® No current artificial feeding ( parenteral ) No lowsodium diet No renal , cardiac , respiratory hepatic insufficiency No chronic inflammatory disease ( intestinal ) No current corticosteroid treatment Fasting blood glucose 6mmol/L Patient able understand benefit risk protocol Women childbearing potential must negative serum pregnancy test agree use medically acceptable method contraception throughout study 15 day follow end study Signed informed consent Subject fulfil inclusion criterion Subject mention article L11215 L11218 `` code de la santé publique '' Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Nutrition , protein metabolism , stable isotope , mass spectrometry , intestinal failure</keyword>
</DOC>